Related Experiment Videos
A continuous spectrophotometric assay for phospholipase A(2) activity.
M Jiménez1, J Cabanes, F Gandía-Herrero
1Departamento de Bioquímica y Biología Molecular A, Universidad de Murcia, Espinardo 30071, Murcia, Spain. mja@um.es
Analytical Biochemistry
|July 5, 2003
Summary
A new spectrophotometric method accurately measures phospholipase A(2) (PLA(2)) activity using a coupled enzymatic assay. This simple, rapid, and cost-effective assay is ideal for studying PLA(2) enzymes and their inhibitors.
Area of Science:
- Biochemistry
- Enzymology
Background:
- Phospholipase A(2) (PLA(2)) plays a critical role in various biological processes.
- Accurate and efficient methods for quantifying PLA(2) activity are essential for research and drug discovery.
Purpose of the Study:
- To develop a simple, continuous, and cost-effective spectrophotometric method for assaying phospholipase A(2) activity.
- To characterize the kinetic parameters and optimal conditions for the developed assay.
Main Methods:
- A coupled enzymatic assay was employed using dilinoleoyl phosphatidylcholine as the substrate for PLA(2) and lipoxygenase as the coupling enzyme.
- PLA(2) activity was monitored spectrophotometrically by measuring the increase in absorbance at 234 nm, corresponding to hydroperoxide formation from linoleic acid.
- Optimal concentrations of hog pancreatic PLA(2), lipoxygenase, pH, and deoxycholate were determined.
Main Results:
- The assay demonstrated specificity and high sensitivity for PLA(2) activity.
- Optimal conditions included pH 8.5 and 3mM deoxycholate.
- Phospholipid hydrolysis followed Michaelis-Menten kinetics with V(m)=1.8 microM/min and K(m)=4.5 microM.
- The method is suitable for studying PLA(2) inhibitors.
Conclusions:
- A simple, rapid, and cost-effective continuous spectrophotometric assay for PLA(2) activity has been established.
- The assay utilizes inexpensive, non-radiolabeled natural substrates, making it widely accessible.
- This method provides a valuable tool for biochemical research and the screening of PLA(2) inhibitors.